MORPHIC FORMS OF COMPLEMENT FACTOR D INHIBITORS
This invention provides stable, highly crystalline forms of Complement factor D inhibitors Compound 1 and Compound 2 for advantageous therapeutic pharmaceutical efficacy and dosage form stability.